1.
Aziz Nazha, Carlos G. Romo, Hagop Kantarjian, Jorge Cortes. The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia. Haematologica 2013;98(10):e131-e131; https://doi.org/10.3324/haematol.2013.091678.